Literature DB >> 839614

Unusual complication of therapy with sulfamethoxazole-trimethoprim.

W H Siegel.   

Abstract

The first case of an obstructing stone composed of a pure metabolite of the sulfamethoxazole-trimethoprim combination is reported. Its coincident occurrence with an obstructing calcium oxalate stone, producing oligura and acute azotemia, is noteworthy.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 839614     DOI： 10.1016/s0022-5347(17)58476-1

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  7 in total

1.  Drug-induced urinary calculi.

Authors:  Brian R Matlaga; Ojas D Shah; Dean G Assimos
Journal:  Rev Urol       Date:  2003

Review 2.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

3.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 4.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

6.  Sulfamethoxazole-induced sulfamethoxazole urolithiasis: a case report.

Authors:  Megan M Roedel; Stephen Y Nakada; Kristina L Penniston
Journal:  BMC Urol       Date:  2021-09-17       Impact factor: 2.264

7.  A rare case of pure N4-acetyl-sulfamethoxazole nephrolithiasis associated with trimethoprim-sulfamethoxazole treatment of pulmonary nocardiosis.

Authors:  Andrew Shanholtzer; Alexander Geisenhoff; Mit Shah; Sugandh Shetty
Journal:  Urol Case Rep       Date:  2022-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.